PER
Click for more information
5.00% 8.4¢ percheron therapeutics limited

Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK, page-30

  1. Sander51
    2,950 Posts.
    lightbulb Created with Sketch. 481
    clock Created with Sketch.
    28/06/23
    10:34
    Post #: 68507476
    Yeah, I think we are all trying to remain positive - it's just the market's response every time that is so depressing, but the committed holders know that it's only a matter of time before we will be rewarded for our patience

    Cheers
    .
    ANP Price at posting: 6.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 12  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢ 		Change
0.004(5.00%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.0¢ 8.4¢ 8.0¢ $26.89K 328.0K

Buyers (Bids)

No. Vol. Price($)
1 9602 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 58051 1
View Market Depth
Last trade - 16.10pm 03/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.